Circulating interferon alpha protein measured with digital enzyme‐linked immunosorbent assay as a biomarker for modified Rodnan skin score progression in limited systemic sclerosis: comment on the article from Di Donato et al

Documents similaires

• Enhancing predictive biomarkers in limited cutaneous systemic sclerosis: the role of type I interferon score and sex considerations: comment on the article by Di Donato et al
  par: Sheng Li
  Publié: (2025)
• Epitope spreading and systemic sclerosis: comment on the article by Kotani et al
  par: Ranjeet Singh Mahla
  Publié: (2025)
• Reassessing biomarker signatures in RA‐ILD and the impact of gender, environment, and disease activity: comment on the article by Wheeler et al
  par: Bi‐yun Yao, et autres
  Publié: (2025)
• Concordance between ultrasound and physical examination in enthesitis assessment: a call for further investigation: comment on the article by Di Matteo et al
  par: Danxiang Shen, et autres
  Publié: (2025)
• Role of autoantibodies in lupus nephritis: comment on the article by Fava et al
  par: Lingxiang Ran, et autres
  Publié: (2024)